Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World of Culture Times.
Press releases published on April 28, 2025
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
GlobeNewswire
·
April 28, 2025
Presentations at WHS and SAWC to highlight EscharEx’s mechanism of action, preclinical advantages over SANTYL®, and new data in treating VLUs and DFUs Findings reinforce the ongoing Phase III study in VLUs and support the planned DFU trial strategy YAVNE, …
Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025
GlobeNewswire
·
April 28, 2025
- Preclinical data demonstrates synergy of QTX3544 with EGFR inhibitors, broadly enhancing anti-tumor activity - - Data supports ongoing Phase 1 clinical trial for QTX3544 as monotherapy and in combination with cetuximab in patients with KRASG12V mutations …
Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the selection of IL15 …
Global Convention 2025 Empowers Consultants to ‘Go Further’ with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth
GlobeNewswire
·
April 28, 2025
SALT LAKE CITY, April 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion …
IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025
GlobeNewswire
·
April 28, 2025
First gamma-delta (γδ) TCE to demonstrate significant γδ T cell expansion and activation, potentially offering an alternative to conventional CD3-based approaches without significant adverse events such as cytokine release syndrome (CRS) INB-600 TCE …
Colabor Announces the Date of Its First Quarter 2025 Results Conference Call
GlobeNewswire
·
April 28, 2025
SAINT-BRUNO-DE-MONTARVILLE, Quebec, April 28, 2025 (GLOBE NEWSWIRE) -- Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) will release its results for the first quarter ended March 22, 2025, after market close on Thursday, May 1, 2025. A conference …
Groupe Colabor annonce la date de la tenue de la téléconférence pour ses résultats du premier trimestre 2025
GlobeNewswire
·
April 28, 2025
SAINT-BRUNO-DE-MONTARVILLE, Québec, 28 avr. 2025 (GLOBE NEWSWIRE) -- Groupe Colabor Inc. (TSX : GCL) (« Colabor » ou la « Société ») divulguera ses résultats pour le premier trimestre clos le 22 mars 2025, après la fermeture des marchés, jeudi le 1er mai …
DLH to Announce Fiscal 2025 Second Quarter Financial Results
GlobeNewswire
·
April 28, 2025
ATLANTA, April 28, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …
Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase
GlobeNewswire
·
April 28, 2025
Marlton, NJ, April 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it reached an important milestone in the INTEGRA-D™ …
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting
GlobeNewswire
·
April 28, 2025
New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) FLORHAM PARK, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical …
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
GlobeNewswire
·
April 28, 2025
MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …
Embecta to host Analyst and Investor Day on May 22, 2025
GlobeNewswire
·
April 28, 2025
PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in …
Exodus Movement, Inc. to Announce First Quarter 2025 Results on May 12, 2025
GlobeNewswire
·
April 28, 2025
OMAHA, Neb., April 28, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it will release its first quarter financial results on Monday, May 12, 2025, …
BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development
GlobeNewswire
·
April 28, 2025
Overall survival and clinical benefit in Phase 2 continue to outperform historical benchmarks, including very heavily pretreated patients Clinical benefit observed in 83% of evaluable patient sub-group treated with the phase 3 formulation Improved new Bria …
TikTok’s Favorite Foodie Kate Norkeliunas Teams Up with MGA’s Miniverse™ to Launch Make It Mini From Scratch™, The Collectible You Make Yourself
GlobeNewswire
·
April 28, 2025
LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- The original miniature brand where DIY meets collectability, MGA’s Miniverse™, is proud to debut its newest collection, MGA’s Miniverse™ Make It Mini From Scratch™. With more than 4 billion views of # …
Chengdu Will Mark 100-day Countdown to TWG 2025 Chengdu
GlobeNewswire
·
April 28, 2025
CHENGDU, China, April 28, 2025 (GLOBE NEWSWIRE) -- On April 29, on the eve of International Workers' Day, the countdown to the TWG 2025 Chengdu will reach the critical 100-day mark. Chengdu, the host city, is welcoming the upcoming The World Games 2025 …
Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025
GlobeNewswire
·
April 28, 2025
PETAH TIKVA, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced management’s participation in the 20th Annual …
Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity Progression free survival (PFS) data to date represents a near doubling of the benchmarking …
BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025
GlobeNewswire
·
April 28, 2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that President and CEO Niven R. Narain, Ph.D. has been named to The Medicine Maker’s Power List 2025. The annual list …
Hudbay’s Eugene Lei wins Globe and Mail’s Report on Business 2025 Best Executive Award
GlobeNewswire
·
April 28, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that Eugene Lei, Chief Financial Officer at Hudbay, has been recognized as a winner of the Globe and Mail’s Report on …